Gilead Sciences (GILD) Stock Price
$114.8 0.5%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
8 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Gilead Sciences, AI stock picks, stock alerts and much more.
GILD AI Stock Analysis
AI stock analysis for GILD is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Gilead Sciences (GILD) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Gilead Sciences (GILD) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Gilead Sciences (GILD), currently trading at $114.8, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About GILD
-
Gilead Sciences, Inc.
-
Symbol
GILD
-
Market
NASDAQ
-
Industry
Drug Manufacturers - General
-
Market Cap
142.8B
Similar Stocks
 |
Astrazeneca AZN |
$76.59 3.5% |
7 |
 |
Amgen AMGN |
$301.4 0.7% |
6 |
 |
Sanofi SNY |
$49.25 0.2% |
6 |
 |
Biogen BIIB |
$126.6 1% |
5 |
News
GILD Alternative Data
Web Traffic
Gilead Sciences receives an estimated 647513 monthly visitors to gilead.com.
-
Web Traffic
647513
-
Change from Previous Month
5.2%
-
3 Month Change
1.2%
-
YoY Change
1.2%
Facebook Engagement
Gilead Sciences has engaged 140 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
140
-
Daily Change
34.3%
-
1 Month Change
133.3%
-
3 Month Change
600%
-
YoY Change
600%
Youtube Subscribers
Gilead Sciences has 5,830 subscribers on its main Youtube channel, up by 0.7% over the last month.
-
Youtube Subscribers
5830
-
Daily Change
0.2%
-
1 Month Change
0.7%
-
3 Month Change
2.5%
-
YoY Change
2.5%
LinkedIn Followers
721,536 are following Gilead Sciences on LinkedIn, up by 1.7% over the last month.
-
LinkedIn Followers
721536
-
Daily Change
0.1%
-
1 Month Change
1.7%
-
3 Month Change
4.6%
Job Postings
Gilead Sciences has an estimated 287 open job postings, which is down -13.3% over the last month.
-
Job Postings
287
-
Daily Change
1.7%
-
1 Month Change
13.3%
-
3 Month Change
20.9%
-
YoY Change
20.9%
LinkedIn Employees
According to LinkedIn, Gilead Sciences has 14,674 employees, down by -0.1% over the last month.
-
LinkedIn Employees
14674
-
Daily Change
0.1%
-
1 Month Change
0.1%
-
3 Month Change
0.6%
-
YoY Change
0.6%
Reddit Mentions
Gilead Sciences has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Gilead Sciences has 72,967 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.
-
Twitter Followers
72967
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.2%
-
YoY Change
0.2%
Business Outlook
According to employee reviews, the business outlook among employees at Gilead Sciences is 54 out of 100 (neutral), up by 1.9% over the last month.
-
Business Outlook
54
-
Change from Previous Month
1.9%
-
3 Month Change
1.9%
-
YoY Change
1.9%
News Mentions
Gilead Sciences was mentioned 9 times in the news yesterday.
-
News Mentions
9
-
Daily Change
80%
-
1 Month Change
0%
-
3 Month Change
0%
GILD Financials
GILD Key Metrics
-
Total Revenue
$6.7B
-
Net Income
$1.3B
-
Earnings per Share
$1.06
-
Free cash flow
$1.8B
-
EBITDA
$1.9B
-
EBITDA Ratio
0.286336
-
Total Assets
$56.4B
GILD 2-year Revenue & Income
GILD 2-year Free Cash Flow
GILD Technicals
GILD SMA
GILD RSI
FAQ
What's the current price of Gilead Sciences (GILD) Stock?
The price of an Gilead Sciences (GILD) share is $114.8.
What's the market cap of Gilead Sciences?
The current market cap of Gilead Sciences is 142.8B.
Should I buy or sell GILD?
Multiple alternative data signals suggest that Gilead Sciences stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Gilead Sciences a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Gilead Sciences stock. The bullish indicators suggest that Gilead Sciences' growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Gilead Sciences (GILD) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Gilead Sciences stock, given the bullish outlook.
What are some stocks similar to Gilead Sciences (GILD) that investors often compare it to?
Gilead Sciences (GILD) is often compared to similar stocks such as Astrazeneca, Amgen, Sanofi and Biogen.
What is the forecast for Gilead Sciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Gilead Sciences' stock price to be around $121.3 in 2026. Starting from the current price of $114.8, this represents a 5.7% change in price, indicating a bullish outlook for the stock.
How to buy Gilead Sciences (GILD) Stock?
Gilead Sciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Gilead Sciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.